四、我国临床路径的研究现状1.我国推广临床路径的必要性和可行性[3]我国人口众多、卫生资源贫乏,人均收入水平低,病人医疗费用的支付能力差。与之形成鲜明对比的是医疗费用和成本的日益高涨。近20年,国外在控制医疗成本、降低医疗费用方面进行了大量的探索和研究,80年代中期开始的临床路径就是较突出的一种模式。 Fourth, the clinical pathway of China’s research status 1. The necessity and feasibility of China to promote clinical pathway [3] China’s large population, lack of health resources, low per capita income, the poor ability of patients to pay medical expenses. In stark contrast to the medical costs and costs of rising. In the past 20 years, a great deal of exploration and research have been carried out in foreign countries in controlling medical costs and reducing medical expenses. The clinical path begun in the mid-1980s is a more prominent model.